The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
novartis | 35182 |
alcon | 1469 |
irm | 1085 |
novartis pharmaceuticals | 1063 |
novartis vaccines and diagnostics | 876 |
glaxosmithkline biologicals | 582 |
alcon research | 512 |
glaxosmithkline | 358 |
merial | 213 |
xoma technology | 163 |
novartis | 3767 |
alcon | 371 |
novartis pharmaceuticals | 326 |
novartis vaccines and diagnostics | 104 |
irm | 90 |
smithkline beecham corporation | 61 |
speedel experimenta | 57 |
alcon research | 44 |
nektar therapeutics | 31 |
xenon pharmaceuticals | 28 |
novartis | 2728 |
glaxosmithkline biologicals | 157 |
elanco tiergesundheit | 26 |
alcon | 17 |
merial | 17 |
alcon research | 16 |
les laboratoires servier | 16 |
arrowhead pharmaceuticals | 15 |
wavelight | 13 |
seqirus uk | 13 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
silicone hydrogel lenses with water-rich surfaces | 130 | 2010 |
cancer treatment | 128 | 2001 |
compounds and compositions as protein kinase inhibitors | 96 | 2006 |
treating dyspnea associated with acute heart failure with relaxin | 94 | 2008 |
capsular polysaccharide solubilisation and combination vaccines | 93 | 2001 |
interval therapy for the treatment of tinnitus | 88 | 2007 |
il-17 antagonistic antibodies | 88 | 2004 |
parasiticidal oral veterinary compositions comprising systemically-acting active agents,… 🛈 | 84 | 2012 |
neisseria meningitidis antigens and compositions | 79 | 1998 |
compounds and compositions as protein kinase inhibitors | 79 | 2009 |